Inflection Pharma Consulting ApS: Financial statements 2021
CVR: 39685507
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Inflection Pharma Consulting ApS (CVR 39685507) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,832 and a net result of DKK -11,890 compared with DKK 36,237 the year before. Equity in the 2021 report amounted to DKK 93,827. The solvency ratio was 82.4%.
- Gross Profit
- DKK -1,832
- Profit/Loss
- DKK -11,890
- Equity
- DKK 93,827
- Total Assets
- DKK 113,869
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2 t. | -12 t. | 94 t. | - |
| 2020 | - | 47 t. | 36 t. | 118 t. | - |
| 2019 | - | 36 t. | 28 t. | 82 t. | - |
Official annual report
Find more companies like Inflection Pharma Consulting ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Inflection Pharma Consulting ApS has published its annual report for 2020. Gross profit came to DKK 47,149, and the net result was DKK 36,237.
About Inflection Pharma Consulting ApS
Inflection Pharma Consulting ApS was a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company has been dissolved on 1 November 2022. The company was registered under the industry Anden teknisk rådgivning. The company was previously named Inflection Pharma Consulting IVS. In 2021, the company reported a gross profit of DKK -1,832 and a net result of DKK -11,890 compared with DKK 36,237 the year before. Equity in the 2021 report amounted to DKK 93,827.